RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$327M
AUM Growth
-$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$7.18M
2 +$6.87M
3 +$6.41M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.4M
5
ALKS icon
Alkermes
ALKS
+$4.2M

Top Sells

1 +$11.5M
2 +$8.22M
3 +$7.28M
4
BIIB icon
Biogen
BIIB
+$6.95M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.58M

Sector Composition

1 Healthcare 82.32%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
101
-23,175
102
-38,773
103
-97,100